“Significantly reduced levels of all the tested eCBs were found in the CSF of patients with MS compared to control subjects."
Link: Abnormalities In The Cerebrospinal Fluid Levels Of Endocannabinoids In Multiple Sclerosis
Year: 2008
DOI: 10.1136/jnnp.2007.139071
Likely probability of the efficacy of cannabis for treatment of Multiple Sclerosis (MS) according to the results found in this study.
Anandamide AEA, PEA, 2-AG, and OEA levels